Global Cardiopulmonary Stress Testing Devices Market Analysis: Monitor Types, Growth Trends and Forecast to 2020

The global cardiopulmonary stress testing devices market to reach nearly USD 5 Billion in 2020, at a CAGR of 9.3% from 2016 to 2020, due to higher prevalence of coronary artery diseases. Cardiopulmonary exercise testing (CPET) devices contributed to the largest share of the global market, and also recorded the fastest growth rate. By geography, North America dominated the overall market growth followed by Europe and Asia Pacific regions. A global trend towards higher incidence of obesity and lifestyle habits has led to increase in the overall cardiopulmonary stress testing devices market.

Browse Cardiopulmonary Stress Testing Devices Market by Monitor Type (CPET/CPEx, Desktop and Portable CPET, Pulse Oximeter, SPECT/SPET, ECG, and Stress Blood Pressure Monitors) 2016-2020 report at https://www.ihealthcareanalyst.com/report/cardiopulmonary-stress-testing-market/

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiac stress test is done with heart stimulation, either by exercise on a treadmill, with the patient connected to an electrocardiogram (ECG). Cardiopulmonary stress testing (CPST) plays an important role in the detection of ischemic heart disease, heart failure, shortness of breath, asthma, and other pulmonary disorders. CPST is a non-invasive and highly sensitive stress test that assesses the response of pulmonary, cardiovascular, neurophysiological, hematopoietic, and skeletal muscle systems to exercise. Cardiopulmonary exercise testing has become an important clinical tool to evaluate exercise capacity and predict outcome in patients with heart failure and other cardiac conditions. It provides assessment of the integrative exercise responses involving the pulmonary, cardiovascular and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function.

The global cardiopulmonary stress testing devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the type of cardiac stress testing monitors used (CPET/CPEx - desktop and portable CPET, pulse oximeter, SPECT/SPET, ECG, and stress blood pressure monitors) and forecasts growth trends (CAGR% - 2016 to 2020). The global cardiopulmonary stress testing devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cardiopulmonary stress testing devices market research report is also segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cardiopulmonary stress testing devices market and included in this report are CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/cardiopulmonary-stress-testing-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 500-7508
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.